LOINC
Version 2.70

97224-0Butalbital [Presence] in Cord tissue by Screen methodActive

Part Description

LP15046-3   Butalbital
Barbiturates were first developed in 1864 by Adolf von Baeyer and were widely distributed by the Farbwerke Fr Bayer and Co in 1904. Barbiturates offered new treatment to patients with psychiatric and neurological disorders profoundly improving their prognoses. Barbiturates were also used to treat sleep disorders and were the first drugs to effectively treat epileptic seizures. Due to safety concerns related to drug dependence and overdose and new safer psychoactive medications barbiturate use sharply declined in the 1950s. [PMID: 18568113] Butalbital, in conjunction with aspirin, acetaminophen and/or caffeine, is used to treat migraine and tension-type headaches. The use of butalbital can lead to intoxication, hangover, tolerance, dependence and toxicity. Patients on high doses of butalbital may experience withdrawal upon discontinuing the drug. [PMID: 11903523] Source: Regenstrief LOINC

Fully-Specified Name

Component
Butalbital
Property
PrThr
Time
Pt
System
TissCo
Scale
Ord
Method
Screen

Additional Names

Short Name
Butalbital TissCo Ql Scn
Display Name
Butalbital Screen Ql (Umb cord tissue)
Consumer Name Alpha
Butalbital, Umbilical cord tissue

Example Answer List LL744-4

Source: Regenstrief Institute

Answer Code Score Answer ID
Detected LA11882-0
Not detected LA11883-8

Basic Attributes

Class
DRUG/TOX
Type
Laboratory
First Released
Version 2.70
Last Updated
Version 2.70
Order vs. Observation
Both

Member of these Groups

LG37556-4 Butalbital|ANYProp|ANYTm|ANYSys|ANYMeth

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=97224-0